Montag, 26.02.2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children (New England Journal of Medicine).
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children (New England Journal of Medicine).